Citrate Precipitation for Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for large-scale purification of proteins, particularly antibodies, face challenges such as lengthy processing times and difficulties in separating proteins from contaminants, with traditional precipitation methods like ammonium sulphate being corrosive and polyethylene glycol (PEG) processes struggling with resuspension and contaminant removal.
Innovation Solution
The use of citrate for protein precipitation, which allows for efficient separation of proteins from contaminants, including small molecular weight contaminants, with the precipitate being readily resolubilized in a small volume of buffer, and subsequent ionic concentration reduction for further purification using ion exchange or hydrophobicity resins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional protein precipitation methods using ammonium sulphate are used, then protein can be precipitated from the mixture, but the precipitant is corrosive and prone to releasing gaseous ammonia
Solution Approach 1:
The patent replaces traditional ammonium sulphate precipitants with citrate, which is less harmful and does not release corrosive gases. This substitution maintains precipitation effectiveness while eliminating the harmful effects of ammonium sulphate, aligning with the principle of using safer, shorter-lived chemical agents that can be easily removed.
Solution Approach 2:
The patent changes the chemical parameters of the precipitation system by using citrate instead of ammonium sulphate. This parameter change (switching precipitant chemistry) maintains the ability to precipitate proteins while eliminating the harmful corrosive and gaseous properties, resolving the contradiction between effectiveness and safety.
2Quantity of substance
If polyethylene glycol (PEG) is used as a precipitant for large scale antibody precipitation, then protein can be precipitated, but the antibody precipitate is difficult to resuspend in aqueous buffers
Solution Approach 1:
The patent uses citrate as a temporary precipitant that forms a precipitate easily removed by centrifugation, followed by resuspension in buffer. The citrate precipitate is designed to be transient and easily handled, contrasting with PEG's persistent and difficult-to-resuspend precipitate. This applies the principle of using a short-lived precipitant that facilitates rather than hinders subsequent processing.
Solution Approach 2:
The patent changes the physical-chemical parameters of precipitation by using citrate instead of PEG. Citrate forms a precipitate with different solubility and aggregation characteristics that are more amenable to resuspension in aqueous buffers, thereby resolving the contradiction between precipitation efficiency and ease of resuspension.
3Manufacturing precision
If large volumes of antibody-containing culture medium are processed by chromatography, then thorough purification can be achieved, but the processing time becomes excessively long
Solution Approach 1:
The patent segments the purification process into two distinct stages: (1) citrate precipitation to concentrate and pre-purify the antibody by removing contaminants, and (2) chromatography to achieve final high-purity product. This segmentation allows the large volume processing to be divided, with the precipitation step rapidly reducing volume and removing bulk contaminants, thereby reducing the time required for the subsequent chromatography step while maintaining overall purification quality.
Solution Approach 2:
The patent performs preliminary action by using citrate precipitation before chromatography to pre-concentrate and pre-purify the antibody. This preliminary step removes a significant portion of contaminants and concentrates the antibody, thereby reducing the burden on the subsequent chromatography step and significantly reducing overall processing time while maintaining high final purity.
4Productivity
If citrate is used to precipitate protein from the mixture, then the precipitate can be readily resolubilized in a small volume of buffer and contaminants separated, but additional steps are required to reduce ionic concentration for chromatography
Solution Approach 1:
The patent extracts the ionic components (citrate and associated ions) from the precipitate through a wash step using a wash buffer. This extraction removes the citrate ions that would interfere with subsequent chromatography, while maintaining the protein precipitate in a form ready for resuspension. This step separates the unwanted ionic components from the desired protein product.
Solution Approach 2:
The patent introduces a wash buffer as an intermediary medium between the citrate precipitation step and the chromatography step. This intermediary wash buffer serves to remove ionic contaminants without dissolving the protein precipitate, thereby bridging the gap between the precipitation and chromatography processes and enabling smooth transition between these steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high recovery rates of intact protein (>80%) with reduced contaminant levels (<2 μg/mL) and efficient processing, enabling faster and more effective protein purification with improved chromatographic compatibility.
Implementation Method 1
adding citrate to the mixture to precipitate the protein and thereby separate it from the mixture
Implementation Method 2
reducing the ionic concentration of the precipitate, thereby allowing the protein to be captured by ion exchange, hydrophobicity and mixed mode affinity resins
Data Source
AI summary
The invention provides methods for isolating proteins in purified form from mixtures by precipitation with citrate. The methods are advantageous in that they effectively separate a protein from lower molecular weight contaminants, including fragments or portions of the protein. Such methods are particularly useful for purifying antibodies from mixtures containing antibody proteolytic fragments and unpaired chains.